首页|Primary △4-3-oxosteroid 5β-reductase deficiency: Two cases in China

Primary △4-3-oxosteroid 5β-reductase deficiency: Two cases in China

扫码查看
Aldo-keto reductase 1D1 (AKR1D1) deficiency,a rare but life-threatening form of bile acid deficiency,has not been previously described in China.Here,we describe the first two primary △4-3-oxosteroid 5β-reductase deficiency patients in Mainland China diagnosed by fast atom bombardment-mass spectroscopy of urinary bile acids and confirmed by genetic analysis.A high proportion of atypical 3-oxo-A4-bile acids in the urine indicated a deficiency in A4-3-oxosteroid 5β-reductase.All of the coding exons and adjacent intronic sequence of the AKR1D1 gene were sequenced using peripheral lymphocyte genomic DNA of two patients and one of the patient's parents.One patient exhibited compound heterozygous mutations:c.396C>A and c.722A>T,while the other was heterozygous for the mutation c.797G>A.Based on these mutations,a diagnosis of primary △4-3-oxosteroid 5β-reductase deficiency could be confirmed.With ursodeoxycholic acid treatment and fat-soluble vitamin supplements,liver function tests normalized rapidly,and the degree of hepatomegaly was markedly reduced in both patients.

Primary △4-3-oxosteroid 5β-reductase geneCholestasisBile acid therapyAldo-keto reductase 1D1Bile acid synthetic defects

Jing Zhao、Ling-Juan Fang、Kenneth DR Setchell、Rui Chen、Li-Ting Li、Jian-She Wang

展开 >

Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai 201102, China

Department of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States

Department of Pediatrics, Jinshan Hospital of Fudan University, Shanghai 201508, China

国家自然科学基金

81070281

2012

世界胃肠病学杂志(英文版)
太原消化病研治中心

世界胃肠病学杂志(英文版)

SCI
影响因子:1.001
ISSN:1007-9327
年,卷(期):2012.18(47)
  • 7
  • 9